Ulthera

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Ulthera sits in the top decile of US sponsors by registered trial count (#420 of 15,742 sponsors by registered trial count).

42 total trials none currently recruiting 35 completed top decile by trial count

Ulthera: 42 sponsored US clinical trials, none currently recruiting.

Ulthera sponsors 42 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 35 completed. The most-studied condition in this pipeline is Skin Laxity, with 3 trials.

Top-decile sponsor footprint

Ulthera ranks in the top decile of sponsors by registered trial count (#420 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 48/100

35 of 42 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

42 total, page 1 of 1

TERMINATED NA

Simulines Non-Inferiority Pivotal Study

NCT02736825

COMPLETED NA

Evaluation of the Ulthera® System and Efficacy Correlation to Morphological Differences

NCT03599349

TERMINATED NA

Gene Expression Following Ultherapy® Treatment

NCT02441036

COMPLETED

Retrospective Evaluation of Combination Treatment With the Ulthera System

NCT02444169

COMPLETED NA

Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines Transducers

NCT02416076

COMPLETED NA

Ultherapy for the Treatment of Spider Veins on the Legs

NCT02286804

COMPLETED NA

Ulthera® System for Treating Axillary Hyperhidrosis

NCT02286765

COMPLETED NA

Ultherapy for Buttock Lift

NCT02270892

COMPLETED NA

Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea

NCT02144181

COMPLETED NA

Ultherapy® for the Treatment of Acne Scars

NCT02145364

TERMINATED NA

Peri-orbital and Peri-oral Wrinkle Reduction Trial

NCT01981252

TERMINATED NA

Feasibility Study: Evaluation of the Ulthera® System for Improvement of Surgical Scars.

NCT01883414

COMPLETED NA

Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment

NCT01810484

TERMINATED NA

A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis

NCT01722461

COMPLETED NA

Evaluation of the Ulthera System for the Treatment of the Decolletage

NCT01713686

TERMINATED NA

Feasibility Study: Histological Characterization After Treatment With the Ulthera® System

NCT01713569

COMPLETED NA

Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck

NCT01713985

COMPLETED NA

Feasibility Study: Heavy Water Tissue Labeling Protocol

NCT01708525

COMPLETED NA

Histological Analysis Following Ulthera System Treatment for Hyperhidrosis

NCT01708551

COMPLETED NA

Feasibility Study: Higher Density Ulthera® System Treatment With Vectoring for Treatment of the Face and Neck

NCT01708512

COMPLETED NA

Feasibility Study: Evaluation of the Ulthera® System for Treatment of Abdominal Tissue

NCT01708499

COMPLETED NA

Feasibility Study: Ulthera Treatment of the Buttocks and Thighs

NCT01708460

COMPLETED NA

Feasibility Study: Safety and Efficacy of the Ulthera® System for Treatment of Axillary Hyperhidrosis

NCT01713673

COMPLETED

A Retrospective Study to Evaluate the Effectiveness of the Ulthera System

NCT01519934

COMPLETED NA

Feasibility Study: Lifting and Tightening of the Elbows

NCT01708382

COMPLETED NA

Treatment of the Face and Neck With Lower Ulthera System Energy Settings

NCT01713998

COMPLETED NA

Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera Treatment

NCT01708252

COMPLETED NA

Feasibility Study: Ulthera® System for the Treatment of Axillary Hyperhidrosis

NCT01713959

COMPLETED NA

Feasibility Study: Ulthera® System for the Treatment of Moderate to Severe Facial Acne

NCT01591304

COMPLETED NA

Lifting and Tightening of the Face and Neck Following an Increased Density Treatment

NCT01519206

COMPLETED NA

Feasibility Study: Evaluate the Effectiveness of Using a Topical Anesthetic Prior to Ultherapy™ Treatment

NCT01708447

COMPLETED NA

Feasibility Study: Compare the Effectiveness Between Two Pain Medications When Used Prior to Ultherapy™ Treatments

NCT01708473

COMPLETED NA

Evaluation of the Ulthera® System for Treatment of the Brachia

NCT01713933

COMPLETED NA

Feasibility Study: Evaluation of the Ulthera® System for Treatment of the Knees

NCT01708434

COMPLETED NA

Feasibility Study: Evaluation of the Ulthera® System for Treatment of the Décolleté

NCT01485107

TERMINATED NA

Evaluation of the Ulthera® System for Treatment of the Face and Neck

NCT01713907

COMPLETED NA

Ultherapy™ Treatment Following Sculptra® Treatment

NCT01422538

COMPLETED NA

Reducing Wrinkles Around the Eyes Using the Ulthera® System

NCT01368900

COMPLETED NA

Lifting and Tightening of the Face and Neck Utilizing the Ulthera® System

NCT01368874

COMPLETED NA

Lifting and Tightening of the Face in Subjects With Skin of Darker Color

NCT01368965

COMPLETED NA

Feasibility Study: Lifting and Tightening Neck Skin in Patients

NCT01708928

COMPLETED NA

Evaluation of the Effectiveness and Safety of the Ulthera™ System for the Treatment of Wrinkles Around the Eyes

NCT00747422

How the Ulthera archive is shaped

42 indexed studies, none listed as recruiting (0% open); 35 completed (83%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Skin Laxity (3 trials), 6 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Ulthera: archived-pipeline peers nationwide

Peers matched on 42 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Ulthera sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01020304050 0%5%10%15%20% Total trials Recruiting share UltheraAcademic and Community Cancer Research UnitedAscensia Diabetes CareAvid RadiopharmaceuticalsCelldex Therapeutics10xBio22nd Century Group23andMe3-C Institute for Social Development
Ulthera sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Ulthera sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 42 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Ulthera page

42 registered trials is a research-attention snapshot, not an endorsement of Ulthera or any single study.

  • None of Ulthera's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Skin Laxity is the condition Ulthera studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Skin Laxity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Ulthera pipeline card: 42 registered trials from official public datasets.Report a data error.